Silver Spring, MD, United States of America

Jean M Muderhwa


Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Jean M. Muderhwa

Introduction

Jean M. Muderhwa is a notable inventor based in Silver Spring, Maryland, recognized for his contributions to the field of immunology and pharmaceutical formulations. With two patents to his name, his work has significant implications for vaccine development and drug delivery systems.

Latest Patents

Muderhwa's latest patents include innovative immunogenic compositions and a unique liposomal formulation. The immunogenic composition describes a stable oil-in-water emulsion characterized by a continuous water phase and a discontinuous oil phase, utilizing smectic mesophase vesicles and their disintegrated forms as the stabilizing agent. This formulation is particularly useful as an adjuvant in vaccines or drug delivery systems. His liposomal formulation patent addresses the stability issues encountered when certain antigens are encapsulated in the presence of alum, proposing the use of a nonionic detergent to maintain stability.

Career Highlights

Throughout his career, Jean M. Muderhwa has worked with esteemed organizations such as Jenner Biotherapies, Inc. and the United States of America as represented by the Secretary of the Army. His expertise in formulating effective immunological compounds has led to advancements in vaccine technology.

Collaborations

Muderhwa has collaborated with notable individuals in the field, including Carl R. Alving and Lynn E. Spitler. These partnerships have further enriched his work, fostering a collaborative approach to research and innovation in immunotherapy.

Conclusion

Jean M. Muderhwa's innovative contributions are vital in the ongoing quest to develop effective vaccines and therapies. His portfolio of patents reflects a commitment to advancing the science of immunology, ultimately benefiting public health and medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…